Moustafa Abdou: Tumor Lysis Syndrome Is a Preventable but Life-Threatening Oncologic Emergency
Moustafa Abdou, Author and Founder of AskHematologist.com, shared a post on LinkedIn:
”Tumor Lysis Syndrome (TLS): Preventable, Yet Potentially Fatal
Tumor Lysis Syndrome remains one of the most critical oncologic emergencies in clinical practice. Rapid tumor cell breakdown can lead to severe metabolic disturbances, including hyperkalemia, hyperuricemia, and acute kidney injury, with potentially life-threatening consequences.
Importantly, TLS is no longer confined to high-grade lymphomas and acute leukemias. With the increasing use of targeted therapies, it is now recognized across a broader spectrum of malignancies.
Early risk stratification, close monitoring, and timely intervention, including hydration and appropriate use of agents such as rasburicase, are essential to improving patient outcomes.”
Stay updated with Hemostasis Today.
-
May 1, 2026, 15:06Ahmed Koriesh: Celebrating Our Stroke Team and Award Recipients at CCF Florida
-
May 1, 2026, 14:57IACH 2026 Travel Grant and Free Registration for Young Professionals
-
May 1, 2026, 14:56Serena Miranda: Why My Stroke Recovery Made Disability Insurance Personal
-
May 1, 2026, 14:43Michael Makris։ A New NEJM Paper Shows Results for Mim8, a Drug Similar to Emicizumab
-
May 1, 2026, 14:32Mark Crowther: Evidence-Based Guidance for Anticoagulant Prophylaxis in Children
-
May 1, 2026, 14:16Violeta Jardin: Precision-Guided Systemic Thrombolysis in High-Risk PE
-
May 1, 2026, 14:11Austin Manning: Mercy San Juan Medical Center’s Role in Kristen’s Stroke Recovery and Hope
-
May 1, 2026, 14:01Andrew M. Ibrahim: AI in Stroke Care and the Evidence Gap in Healthcare Delivery
-
May 1, 2026, 13:55Join the ISBT Webinar on AI in Transfusion Medicine